• Items
  • Login
  • Renew Now

Stereotactic Body Radiotherapy: The Future of Radiotherapy or More Trouble Than It’s Worth?

Add to Cart
Back to Results
No continuing education / Category A credit assigned to this presentation.
This session was recorded at CONNECT 2019.

Presenters: Shannah Murland, MRT(T), HBSc, PgC

Learning Objectives:
Stereotactic body radiotherapy (SBRT) has been used in Alberta for over 10 years and has expanded from early stage lung cancer to liver cancer and metastases, bone and spine metastases and almost any feasible body site. SBRT is a truly collaborative treatment approach that requires radiation oncologists, physicists, dosimetrists and radiation therapists to work together to design an appropriate treatment plan for small tumours that may have significant motion with respiration or be very close to critical structures. The use of fluoroscopy, MRI, CT and PET in target definition and immobilization planning shows the importance of multi-modality imaging in this patient population. The use of SBRT must be balanced with clinical and patient benefits and radiotherapy departments must determine what level of resources they can allocate to this specialty program.

Member Price: $0.00
Non-Member Price: $20.00

Assign Members : 
Members Assigned | Assign all contacts Unassign all contacts

  • All
  • Assigned
  • Unassigned
Add New Contact

Add New Contact





Cancel
Save

Assign Full Name Account Name Email/Username Role
Total Records - Showing Page

Discounts and special pricing for additional items will be applied once you add the item to your cart.
Previous Next

© 2017

CAMRT / ACTRM Logo
twitterfacebookYouTubelinkedin